UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2022
Commission File Number 001-33098
Mizuho Financial Group, Inc.
(Translation of registrant’s name into English)
5-5, Otemachi 1-chome
Chiyoda-ku, Tokyo 100-8176
Japan
(Address of principal executive office)
Indicate by check mark... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 12, 2022
UNITY BIOTECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Delaware 001-38470 26-4726035
(State or other... (continue reading...)
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 12, 2022 (July 11, 2022)
PROKIDNEY CORP.
(Exact name of Registrant as Specified in Its Charter)
... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B3 Xos, Inc.
-
Form 13F-HR Dynamic Technology Lab For: Jun 30
-
Form 10-Q Sidus Space Inc. For: Jun 30
-
Form 8-K Unity Biotechnology, For: Aug 12
-
Form 8-K Aptinyx Inc. For: Aug 12
-
Form 8-K Iterum Therapeutics plc For: Aug 12
-
Form 10-Q Venus Concept Inc. For: Jun 30
-
Form 8-K LEAP THERAPEUTICS, INC. For: Aug 11
-
Form 8-K Venus Concept Inc. For: Aug 12
-
Form 6-K PEARSON PLC For: Aug 12
-
Form 8-K Chemomab Therapeutics For: Aug 12
-
Form 10-Q ATHERSYS, INC / NEW For: Jun 30
-
Form 8-K Applied Therapeutics For: Aug 12
-
Form 8-A12B RAPID MICRO BIOSYSTEMS,
-
Form 8-K Humacyte, Inc. For: Aug 12
-
Form 8-K Instil Bio, Inc. For: Aug 12
-
Form D/A Rokos Global Macro Fund
-
Form 8-K Real Good Food Company, For: Aug 12
-
Form 6-K Americas Gold & Silver For: Aug 12
-
Form 6-K Orla Mining Ltd. For: Aug 12
-
Form 8-K Ampio Pharmaceuticals, For: Aug 10
-
Form 6-K MAVERIX METALS INC. For: Aug 12
-
Form 10-Q ProMIS Neurosciences For: Jun 30
-
Form 10-K NEWS CORP For: Jun 30
-
Form 13F-HR DSM CAPITAL PARTNERS For: Jun 30
-
Form D/A Rokos Global Macro Fund
-
Form 8-K PLx Pharma Inc. For: Aug 12
-
Form 4 VOXX International Corp For: Aug 11 Filed by: Kahli Beat
-
Form 6-K NXT Energy Solutions For: Aug 11
-
Form 6-K Americas Gold & Silver For: Aug 12
-
Form D/A Rokos Global Macro Fund
-
Form 6-K PRUDENTIAL PLC For: Aug 12
-
Form 6-K MIZUHO FINANCIAL GROUP For: Aug 12
-
Form 13F-HR Eisler Capital (UK) Ltd. For: Jun 30
-
Form 6-K Brookfield Business Part For: Aug 12
-
Form 6-K Brookfield Business Corp For: Aug 12
-
Form 13F-HR China Universal Asset For: Jun 30
-
Form 10-Q Unity Biotechnology, For: Jun 30
-
Form 6-K ASLAN Pharmaceuticals For: Jun 30
-
Form 13F-HR Asia Research & Capital For: Jun 30
-
Form 10-Q LEAP THERAPEUTICS, INC. For: Jun 30
-
Form 6-K Sands China Ltd. For: Aug 12
-
Form 6-K NatWest Group plc For: Aug 12
-
Form 6-K MITSUBISHI UFJ FINANCIAL For: Aug 12
-
Form ABS-15G NOMURA ASSET ACCEPTANCE For: Jun 30
-
Form 6-K RYANAIR HOLDINGS PLC For: Aug 12
-
Form ABS-15G Nomura Home Equity Loan, For: Jun 30
-
Form SC 13D/A Wave Life Sciences Ltd. Filed by: Shin Nippon Biomedical Laboratories, Ltd.
-
Form 4 TELA Bio, Inc. For: Aug 10 Filed by: Opaleye Management Inc.
-
Form 424B5 Broadstone Net Lease,
